Regeneration of diabetic axons is enhanced by selective knockdown of the PTEN gene

Brain

Volumn 137, Issue 4, 2014, Pages 1051-1067

  Singh, Bhagat ^a   Singh, Vandana ^a   Krishnan, Anand ^a   Koshy, Kurien ^a   Martinez, Jose A ^a   Cheng, Chu ^a   Almquist, Chris ^a   Zochodne, Douglas W ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

axonal injury; diabetes; diabetic polyneuropathy; peripheral nerve; peripheral nervous system

Indexed keywords

MESSENGER RNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SMALL INTERFERING RNA; PTEN PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; ELECTROPHYSIOLOGY; GENE SILENCING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOUSE; MUSCLE ACTION POTENTIAL; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCIATIC NERVE INJURY; SENSORY NERVE CELL; SPINAL GANGLION; UPREGULATION; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; GENETICS; METABOLISM; NERVE CRUSH; NERVE FIBER; NERVE REGENERATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; AXONS; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; GENE KNOCKDOWN TECHNIQUES; IMMUNOHISTOCHEMISTRY; MALE; MICE; NERVE CRUSH; NERVE REGENERATION; PTEN PHOSPHOHYDROLASE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84897867184     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awu031     Document Type: Article

References (61)

1. Ali IU, Schriml LM, Dean M. Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J Natl Cancer Inst 1999; 91: 1922-32.
2. Andersen PL, Webber CA, Kimura KA, Schreyer DJ. Cyclic AMP prevents an increase in GAP-43 but promotes neurite growth in cultured adult rat dorsal root ganglion neurons. Exp Neurol 2000; 166: 153-65.
3. Brewster WJ, Fernyhough P, Diemel LT, Mohiuddin L, Tomlinson DR. Diabetic neuropathy, nerve growth factor and other neurotrophic factors. Trends Neurosci 1994; 17: 321-5.
4. Bril V. Role of electrophysiological studies in diabetic neuropathy. Can J Neurol Sci 1994; 21 (Suppl 4): S8-12.
5. Carter AN, Downes CP. Phosphatidylinositol 3-kinase is activated by nerve growth factor and epidermal growth factor in PC12 cells. J Biol Chem 1992; 267: 14563-7.
6. Cheng C, Guo GF, Martinez JA, Singh V, Zochodne DW. Dynamic plasticity of axons within a cutaneous milieu. J Neurosci 2010; 30: 14735-44.
7. Chitwood DH, Timmermans MC. Small RNAs are on the move. Nature 2010; 467: 415-19.
8. Christie KJ, Webber CA, Martinez JA, Singh B, Zochodne DW. PTEN inhibition to facilitate intrinsic regenerative outgrowth of adult peripheral axons. J Neurosci 2010; 30: 9306-15.
9. Conti G, Stoll G, Scarpini E, Baron PL, Bianchi R, Livraghi S, et al. p75 neurotrophin receptor induction and macrophage infiltration in peripheral nerve during experimental diabetic neuropathy: possible relevance on regeneration. Exp Neurol 1997; 146: 206-11.
10. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester diabetic neuropathy study. Neurology 1993; 43: 817-24.
11. Eickholt BJ, Walsh FS, Doherty P. An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling. J Cell Biol 2002; 157: 211-17.
12. Gallo G, Letourneau PC. Localized sources of neurotrophins initiate axon collateral sprouting. J Neurosci 1998; 18: 5403-14.
13. Glazner GW, Lupien S, Miller JA, Ishii DN. Insulin-like growth factor II increases the rate of sciatic nerve regeneration in rats. Neuroscience 1993; 54: 791-7.
14. GrandPre T, Li S, Strittmatter SM. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 2002; 417: 547-51.
15. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32: 77-88.
16. Hu Z, Lee IH, Wang X, Sheng H, Zhang L, Du J, et al. PTEN expression contributes to the regulation of muscle protein degradation in diabetes. Diabetes 2007; 56: 2449-56.
17. Ishii DN, Lupien SB. Insulin-like growth factors protect against diabetic neuropathy: effects on sensory nerve regeneration in rats. J Neurosci Res 1995; 40: 138-44.
18. Jones DM, Tucker BA, Rahimtula M, Mearow KM. The synergistic effects of NGF and IGF-1 on neurite growth in adult sensory neurons: convergence on the PI 3-kinase signaling pathway. J Neurochem 2003; 86: 1116-28.
19. Kan M, Guo G, Singh B, Singh V, Zochodne DW. Glucagon-like peptide 1, insulin, sensory neurons, and diabetic neuropathy. J Neuropathol Exp Neurol 2012; 71: 494-510.
20. Kaspar BK, Erickson D, Schaffer D, Hinh L, Gage FH, Peterson DA. Targeted retrograde gene delivery for neuronal protection. Mol Ther 2002; 5: 50-6.
21. Kennedy JM, Zochodne DW. The regenerative deficit of peripheral nerves in experimental diabetes: its extent, timing and possible mechanisms. Brain 2000; 123: 2118-29.
22. Kennedy JM, Zochodne DW. Influence of experimental diabetes on the microcirculation of injured peripheral nerve: Functional and morphological aspects. Diabetes 2002; 51: 2233-40.
23. Kennedy JM, Zochodne DW. Experimental diabetic neuropathy and spontaneous recovery: Is there irreparable damage? Diabetes 2005; 54: 830-7.
24. Kennedy WR, Navarro X, Goetz FC, Sutherland DE, Najarian JS. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 1990; 322: 1031-7.
25. Koistinen HA, Chibalin AV, Zierath JR. Aberrant p38 mitogen-activated protein kinase signalling in skeletal muscle from Type 2 diabetic patients. Diabetologia 2003; 46: 1324-8.
26. Leclere PG, Norman E, Groutsi F, et al. Impaired axonal regeneration by isolectin B4-binding dorsal root ganglion neurons in vitro. J Neurosci 2007; 27: 1190-9.
27. Leslie NR, Downes CP. PTEN: The down side of PI 3-kinase signalling. Cell Signal 2002; 14: 285-95.
28. Lindsay RM. Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons. J Neurosci 1988; 8: 2394-405.
29. Liu K, Lu Y, Lee JK, Samara R, Willenberg R, Sears-Kraxberger I, et al. PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat Neurosci 2010; 13: 1075-81.
30. Longo FM, Powell HC, Lebeau J, Gerrero MR, Heckman H, Myers RR. Delayed nerve regeneration in streptozotocin diabetic rats. Muscle Nerve 1986; 9: 385-93.
31. Love A, Cotter MA, Cameron NE. Impaired myelinated fiber regeneration following freeze-injury in rats with streptozotocin-induced diabetes: involvement of the polyol pathway. Brain Res 1995; 703: 105-10.
32. Malik RA, Veves A, Walker D, Siddique I, Lye RH, Schady W, et al. Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve elec-trophysiology. Acta Neuropathol 2001; 101: 367-74.
33. Mehra S, Tavakoli M, Kallinikos PA, Efron N, Boulton AJ, Augustine T, et al. Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes. Diabetes Care 2007; 30: 2608-12.
34. Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ, et al. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 2005; 353: 2012-24.
35. Mukhopadhyay G, Koherty P, Walsh FS, Crocker PR, Filbin MT. A novel role for myelin-assocaited glycoprotein as an inhibitor of axonal regeneration. Neuron 1994; 13: 757-67.
36. Nakae J, Biggs WH III, Kitamura T, Cavenee WK, Wright CV, Arden KC, et al. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet 2002; 32: 245-53.
37. Ohnishi A, O'Brien PC, Dyck PJ. Studies to improve fixation of human nerves. Part 3. Effect of osmolality of glutaraldhyde solutions on relationship of axonal area to number of myelin lamellae. J Neurol Sci 1976; 27: 193-9.
38. Pal A, Barber TM, Van de Bunt M, Rudge SA, Zhang Q, Lachlan KL, et al. PTEN mutations as a cause of constitutive insulin sensitivity and obesity. N Engl J Med 2012; 367: 1002-11.
39. Park KK, Liu K, Hu Y, Kanter JL, He Z. PTEN/mTOR and axon regeneration. Exp Neurol 2010; 223: 45-50.
40. Park KK, Liu K, Hu Y, Smith PD, Wang C, Cai B, et al. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 2008; 322: 963-6.
41. Polydefkis M, Hauer P, Griffin JW, McArthur JC. Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy. Diabetes Technol Ther 2001; 3: 23-8.
42. Raffioni S, Bradshaw RA. Activation of phosphatidylinositol 3-kinase by epidermal growth factor, basic fibroblast growth factor, and nerve growth factor in PC12 pheochromocytoma cells. Proc Natl Acad Sci USA 1992; 89: 9121-5.
43. Schnell L, Schneider R, Kolbeck R, Barde YA, Schwab ME. Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature 1994; 367: 170-3.
44. Sima AA, Bril V, Nathaniel V, McEwen TA, Brown MB, Lattimer SA, et al. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. N Engl J Med 1988; 319: 548-55.
45. Singh B, Xu Y, McLaughlin T, Singh V, Martinez JA, Krishnan A, et al. Resistance to trophic neurite outgrowth of sensory neurons exposed to insulin. J Neurochem 2012; 121: 263-76.
46. Soltoff SP, Rabin SL, Cantley LC, Kaplan DR. Nerve growth factor promotes the activation of phosphatidylinositol 3-kinase and its association with the trk tyrosine kinase. J Biol Chem 1992; 267: 17472-7.
47. Terada M, Yasuda H, Kikkawa R. Delayed Wallerian degeneration and increased neurofilament phosphorylation in sciatic nerves of rats with streptozocin-induced diabetes. J Neurol Sci 1998; 155: 23-30.
48. Triban C, Guidolin D, Fabris M, Marini P, Schiavinato A, Donà M, et al. Ganglioside treatment and improved axonal regeneration capacity in experimental diabetic neuropathy. Diabetes 1989; 38: 1012-22.
49. Waite KA, Eng C. Protean PTEN: form and function. Am J Hum Genet 2002; 70: 829-44.
50. Wang XL, Zhang L, Youker K, Zhang MX, Wang J, LeMaire SA, et al. Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. Diabetes 2006; 55: 2301-10.
51. Webber CA, Christie KJ, Cheng C, Martinez JA, Singh B, Singh V, et al. Schwann cells direct peripheral nerve regeneration through the netrin-1 receptors, DCC and Unc5H2. Glia 2011; 59: 1503-17.
52. Williams SK, Howarth NL, Devenny JJ, Bitensky MW. Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus. Proc Natl Acad Sci USA 1982; 79: 6546-50.
53. Xu G, Pierson CR, Murakawa Y, Sima AA. Altered tubulin and neurofila-ment expression and impaired axonal growth in diabetic nerve regeneration. J Neuropathol Exp Neurol 2002; 61: 164-75.
54. Xu G, Sima AA. Altered immediate early gene expression in injured diabetic nerve: implications in regeneration. J Neuropathol Exp Neurol 2001; 60: 972-83.
55. Yamamoto Y, Yasuda Y, Kimura Y, Komiya Y. Effects of cilostazol, an antiplatelet agent, on axonal regeneration following nerve injury in diabetic rats. Eur J Pharmacol 1998; 352: 171-8.
56. YasudaH, TeradaM, MaedaK, KogawaS, SanadaM, HanedaM, etal.Diabetic neuropathy and nerve regeneration. Prog Neurobiol 2003; 69: 229-85.
57. Yasuda H, Terada M, Taniguchi Y, Sasaki T, Maeda K, Haneda M, et al. Impaired regeneration and no amelioration with aldose reductase inhibitor in crushed unmyelinated nerve fibers of diabetic rats. NeuroReport 1999; 10: 2405-9.
58. Zherebitskaya E, Akude E, Smith DR, Fernyhough P. Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: role of glucose-induced oxidative stress. Diabetes 2009; 58: 1356-64.
59. Zochodne DW. Diabetic neuropathies: features and mechanisms. Brain Pathol 1999; 9: 369-91.
60. Zochodne DW, Ramji N, Toth C. Neuronal targeting in diabetes mellitus: a story of sensory neurons and motor neurons. Neuroscientist 2008; 14: 311-18.
61. Zochodne DW, Verge VMK, Cheng C, Sun H, Johnston J. Does diabetes target ganglion neurons? Progressive sensory neuron involvement in long term experimental diabetes. Brain 2001; 124: 2319-34.